Response to bistability in apoptosis: Roles of Bax, Bcl-2, and mitochondrial permeability transition pores

Biophysical Journal

Volumn 92, Issue 9, 2007, Pages 3332-3334

  Eissing, Thomas ^a   Waldherr, Steffen ^a   Allgöwer, Frank ^a   Scheurich, Peter ^a   Bullinger, Eric ^a,b  

^a UNIVERSITY OF STUTTGART   (Germany)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; MATHEMATICAL MODEL; MONTE CARLO METHOD; REVIEW; SIGNAL TRANSDUCTION;

EID: 34247555454     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.100362     Document Type: Letter

References (22)

1. Bagci, E. Z., Y. Vodovotz, T. R. Billiar, G. B. Ermentrout, and I. Bahar. 2006. Bistability in apoptosis: roles of Bax, Bcl-2 and mitochondrial permeability transition pores. Biophys. J. 90:1546-1559.
2. Stelling, J., U. Sauer, Z. Szallasi, F. J. Doyle 3rd, and J. Doyle. 2004. Robustness of cellular functions. Cell. 118:675-685.
3. Danial, N. N., and S. J. Korsmeyer. 2004. Cell death: critical control points. Cell. 116:205-219.
4. Eissing, T., H. Conzelmann, E. D. Gilles, F. Allgöwer, E. Bullinger, and P. Scheurich. 2004. Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem. 279:36892-36897.
5. Legewie, S., N. Blüthgen, and H. Herzel. 2006. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput. Biol. 2:e120.
6. Ferrell, J. E., Jr., and W. Xiong. 2001. Bistability in cell signaling: how to make continuous processes discontinuous, and reversible processes irreversible. Chaos. 11:227-236.
7. Angeli, D., J. E. Ferrell, Jr., and E. D. Sontag. 2004. Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc. Natl. Acad. Sci. USA. 101:1822-1827.
8. Craciun, G., Y. Tang, and M. Feinberg. 2006. Understanding bistability in complex enzyme-driven reaction networks. Proc. Natl. Acad. Sci. USA. 103:8697-8702.
9. Eissing, T., S. Waldherr, F. Allgöwer, P. Scheurich, and E. Bullinger. 2007. Steady state and (bi-) stability evaluation of simple protease signalling networks. Biosystems. 10.1016/j.biosystems.2007.01.003.
10. Ma, L., and P. A. Iglesias. 2002. Quantifying robustness of biochemical network models. BMC Bioinformatics. 3:38.
11. Eissing, T., F. Allgöwer, and E. Bullinger. 2005. Robustness properties of apoptosis models with respect to parameter variations and stochastic influences. IEE Syst. Biol. 152:221-228.
12. Deveraux, Q. L., R. Takahashi, G. S. Salvesen, and J. C. Reed. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300-304.
13. Ekert, P. G., J. Silke, and D. L. Vaux. 1999. Caspase inhibitors. Cell Death Differ. 6:1081-1086.
14. Svingen, P. A., D. Loegering, J. Rodriquez, X. W. Meng, P. W. Mesner, S. Holbeck, A. Monks, S. Krajewski, D. A. Scudiero, E. A. Sausville, J. C. Reed, Y. A. Lazebnik, and S. H. Kaufmann. 2004. Components of the cell death machine and drug sensitivity of the National Cancer Institute Cell Line Panel. Clin. Cancer Res. 10:6807-6820.
15. Stennicke, H. R., J. M. Jurgensmeier, H. Shin, Q. Deveraux, B. B. Wolf, X. Yang, Q. Zhou, H. M. Ellerby, L. M. Ellerby, D. Bredesen, D. R. Green, J. C. Reed, C. J. Froelich, and G. S. Salvesen. 1998. Procaspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273:27084-27090.
16. Sun, X. M., S. B. Bratton, M. Butterworth, M. MacFarlane, and G. M. Cohen. 2002. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J. Biol. Chem. 277:11345-11351.
17. Legewie, S., N. Blüthgen, and H. Herzel. 2005. Quantitative analysis of ultrasensitive responses. FEBS J. 272:4071-4079.
18. Wolf, J., S. Becker-Weimann, and R. Heinrich. 2005. Analyzing the robustness of cellular rhythms. IEE Syst. Biol. 2:35-41.
19. Stelling, J., E. D. Gilles, and F. J. Doyle 3rd. 2004. Robustness properties of circadian clock architectures. Proc. Natl. Acad. Sci. USA. 101:13210-13215.
20. Stennicke, H. R., and G. S. Salvesen. 1999. Catalytic properties of the caspases. Cell Death Differ. 6:1054-1059.
21. Rehm, M., H. J. Huber, H. Dussmann, and J. H. M. Prehn. 2006. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J. 25:4338-4349.
22. Manoharan, A., T. Kiefer, S. Leist, K. Schrader, C. Urban, D. Walter, U. Maurer, and C. Borner. 2006. Identification of a "genuine" mammalian homolog of nematodal CED-4: is the hunt over or do we need better guns? Cell Death Differ. 13:1310-1317.